| Literature DB >> 31239852 |
Mohammad K Okla1, Saud A Alamri1, Abdulrahman A Alatar1, Ahmed K Hegazy2, Abdullah A Al-Ghamdi1, Jamaan S Ajarem3, Mohammad Faisal1, Eslam M Abdel-Salam1, Hayssam M Ali1,4, Mohamed Z M Salem5, Mostafa A Abdel-Maksoud3,6.
Abstract
Diabetes mellitus (DM) is a metabolic disease that can affect the central nervous system and behavioral traits in animals. Streptozotocin-induced diabetes is considered an autoimmune disease. The aim of the current study was to determine whether supplementation with the alcoholic extract of Avicennia marina leaves could improve diabetes-associated pathological changes. The animals were divided into four groups: a control group (A), an A. marina receiving nondiabetic group (B), a diabetic group (C), and a DM group orally supplemented with A. marina alcoholic leaf extract (D). The DM group of animals receiving the alcoholic extract of A. marina leaves had reduced blood glucose levels, improved blood picture, and organ functions. This group also showed improvement in locomotory behavior. The results of this study showed that supplementation with the alcoholic extract of A. marina leaves reduced oxidative stress and blood sugar levels, protected the liver, and improved the neurobehavioral changes associated with diabetes in mice. Introducing alcoholic leaf extract of A. marina to diabetic mice decreased inflammatory cells aggregation, vacuolation, and hemorrhage. Additionally, a positive effect of the alcoholic leaf extract on the histopathological changes was observed in the testicular tissue of treated mice.Entities:
Year: 2019 PMID: 31239852 PMCID: PMC6556331 DOI: 10.1155/2019/1263260
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Effect of the alcoholic leaf extract of Avicennia marina on the cell blood count (CBC) in mice.
| Groups of mice | WBC (×109/L) | RBC (×106/mm3) | Hb (g/dl) | HCT (%) | MCV ( | MCH (pg) |
|---|---|---|---|---|---|---|
| Group (A) | 7.9 ± 0.5 | 8.50 ± 0.73 | 15.6 ± 1.8 | 37.9 ± 3.7 | 46.8 ± 3.2 | 17.3 ± 0.4 |
|
| ||||||
| Group (B) | 8.3 ± 0.6 | 8.6 ± 0.63 | 15.9 ± 1.99 | 41.2 ± 5.2 | 47.3 ± 3.7 | 17.8 ± 0.8 |
|
| ||||||
| Group (C) | 6.9 ± 0.8 | 6.84 ± 0.46 | 11.8 ± 1.5 | 43.3 ± 2.8 | 52.8 ± 2.2 | 17.6 ± 0.8 |
|
| ||||||
| Group (D) | 7.4 ± 0.9 | 7.88 ± 0.09 | 14.1 ± 2.1 | 38.6 ± 4.5 | 48.2 ± 3.1 | 17.2 ± 0.6 |
∗P < 0.05 for diabetic group of mice vs. negative control; AM: Avicennia marina; Hb: hemoglobin; HCT: hematocrit; MCH: mean corpuscular hemoglobin; MCV: mean corpuscular volume; RBC: red blood corpuscles; STZ: streptozotocin; WBC: white blood cells.
Effect of the alcoholic leaf extract of Avicennia marina on the mean corpuscular hemoglobin concentration, platelets, neutrophils, lymphocytes, and monocytes in mice.
| Groups of mice | MCHC (%) | Platelets (103/mm3) | Neutrophils % | Lymphocytes % | Monocytes % |
|---|---|---|---|---|---|
| Group (A) | 33.6 ± 1.1 | 998 ± 33 | 24 ± 2.1 | 57 ± 4.4 | 3 ± 0.54 |
|
| |||||
| Group (B) | 33.5 ± 0.7 | 890 ± 70 | 27 ± 2.2 | 68 ± 3.1 | 4 ± 0.66 |
|
| |||||
| Group (C) | 33.8 ± 1.3 | 1015 ± 31 | 29 ± 3.15 | 78 ± 1.6 | 4 ± 0.9 |
|
| |||||
| Group (D) | 32.9 ± 0.9 | 950 ± 60 | 22 ± 2.6 | 52 ± 2.3 | 4 ± 0.25 |
MCHC: mean corpuscular hemoglobin concentration.
Effect of the alcoholic leaf extract of Avicennia marina on blood glucose level (mg/dl) in the experimental groups of mice.
| Experimental group | Glucose (mg/dl) |
|---|---|
| Group (A) | (77.91 ± 3.76) |
|
| |
| Group (B) | (75.5 ± 3.4) |
|
| |
| Group (C) | (131.4 ± 2.97) |
|
| |
| Group (D) | (79.9 ± 4.1)# |
∗P < 0.05 for diabetic group of mice vs. control; #P < 0.05 for diabetic + AM group of mice vs. control. AM: Avicennia marina; STZ: streptozotocin.
Effect of the alcoholic leaf extract of Avicennia marina on liver functions in diabetic mice.
| Groups of mice | ALT (U/l) | Creatinine (mg/dl) |
|---|---|---|
| Group (A) | 25 ± 5.1 | 0.6 ± 0.9 |
|
| ||
| Group (B) | 27 ± 6.4 | 0.66 ± 0.09 |
|
| ||
| Group (C) | 55.6 ± 4.4 | 3.7 ± 0.1 |
|
| ||
| Group (D) | 30 ± 5.3 | 0.7 ± 0.05 |
∗P < 0.05 for diabetic group of mice vs. control. ALT: alanine aminotransferase.
Effect of the alcoholic leaf extract of Avicennia marina on blood testosterone level in mice.
| Experimental group | Testosterone (ng/ml) |
|---|---|
| Group (A) | 0.020 ± 0.002 |
|
| |
| Group (B) | 0.072 ± 0.005 |
|
| |
| Group (C) | 0.026 ± 0.001 |
|
| |
| Group (D) | 0.027 ± 0.003 |
∗P < 0.05 for diabetic group of mice vs. control.
Effect of the alcoholic leaf extract of Avicennia marina on oxidative stress parameters in hepatic tissue of mice.
| Groups of mice | Nitrate | MDA | H2O2 | GSH | CAT |
|---|---|---|---|---|---|
| (mg/gm) | (nmol/gm) | (mMol/gm) | ( | (nmol/sec/gm) | |
| Group (A) | 3.148 ± 0.258 | 363.61 ± 37.21 | 2.179 ± 0.096 | 5.793 ± 0.748 | 9.082 ± 0.990 |
|
| |||||
| Group (B) | 3.367 ± 0.256 | 347.15 ± 16.81 | 2.384 ± 0.088 | 4.198 ± 0.691 | 3.537 ± 0.146 |
|
| |||||
| Group (C) | 5.399 ± 0.196 | 597.54 ± 43.16 | 5.376 ± 0.226 | 2.443 ± 0.424 | 3.719 ± 0.071 |
|
| |||||
| Group (D) | 4.088 ± 0.226 | 401.50 ± 33.97 | 2.620 ± 0.760 | 4.389 ± 0.421 | 11.872 ± 0.318 |
∗P < 0.05 for diabetic group of mice vs. control. CAT: catalase; GSH: reduced glutathione; H2O2: hydrogen peroxide; MDA: malondialdehyde.
Figure 1Effect of the alcoholic extract of Avicennia marina leaves on the locomotory behavior of the diabetic mice in the activity cage. (A) Negative control group; (B) positive control group; (C) diabetic group; (D) diabetic + AM group (STZ + AM leaf extract). Number of movements per second was plotted for the four experimental groups. AM: Avicennia marina; STZ: streptozotocin.
Figure 2Effect of alcoholic leaf extract of Avicennia marina on the tissue sections of liver. (a) Negative control (did not receive any treatment); (b) positive control group receiving the leaf extract; (c) diabetic group (injected with STZ); (d) group receiving STZ + leaf extract. STZ: streptozotocin.
Figure 3Effect of alcoholic leaf extract of Avicennia marina on the tissue sections of testis in mice. (a) Negative control (did not receive any treatment); (b) group receiving the leaf extract; (c) positive control (injected with STZ); (d) group receiving STZ + leaf extract. STZ: streptozotocin.